Pertuzumab: new hope for patients with HER2-positive breast cancer.

Capelan, M

Pertuzumab: new hope for patients with HER2-positive breast cancer. [electronic resource] - Annals of oncology : official journal of the European Society for Medical Oncology Feb 2013 - 273-282 p. digital

Publication Type: Journal Article; Review

1569-8041

10.1093/annonc/mds328 doi


Antibodies, Monoclonal, Humanized--adverse effects
Antineoplastic Agents--adverse effects
Breast Neoplasms--drug therapy
Dimerization
Disease-Free Survival
Female
Humans
Receptor, ErbB-2--immunology
Trastuzumab